Paris - Delayed Quote EUR
Eurofins Scientific SE (ERF.PA)
As of 4:08 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,514,600.00
6,514,600.00
6,712,100.00
6,717,700.00
5,438,800.00
Cost of Revenue
2,151,100.00
2,151,100.00
2,227,000.00
2,149,700.00
1,748,100.00
Gross Profit
4,363,500.00
4,363,500.00
4,485,100.00
4,568,000.00
3,690,700.00
Operating Expense
3,816,700.00
3,816,700.00
3,701,900.00
3,292,700.00
2,885,200.00
Operating Income
546,800.00
546,800.00
783,200.00
1,275,300.00
805,500.00
Net Non Operating Interest Income Expense
-117,800.00
-117,800.00
-103,900.00
-185,500.00
-102,700.00
Pretax Income
423,300.00
423,300.00
780,000.00
1,056,600.00
694,400.00
Tax Provision
115,500.00
115,500.00
174,200.00
273,600.00
153,900.00
Net Income Common Stockholders
310,200.00
310,200.00
610,200.00
782,600.00
539,400.00
Diluted NI Available to Com Stockholders
310,200.00
310,200.00
610,200.00
782,600.00
539,400.00
Basic EPS
1.61
1.61
3.17
4.09
2.90
Diluted EPS
1.57
1.57
3.07
3.90
2.75
Basic Average Shares
192,900.00
192,900.00
192,500.00
191,500.00
186,200.00
Diluted Average Shares
197,900.00
197,900.00
199,000.00
200,600.00
195,900.00
Total Expenses
5,967,800.00
5,967,800.00
5,928,900.00
5,442,400.00
4,633,300.00
Net Income from Continuing & Discontinued Operation
310,200.00
310,200.00
610,200.00
782,600.00
539,400.00
Normalized Income
322,704.40
322,704.40
507,325.20
795,419.30
543,679.00
Interest Income
11,600.00
11,600.00
2,200.00
2,000.00
2,700.00
Interest Expense
129,400.00
129,400.00
105,600.00
95,000.00
103,600.00
Net Interest Income
-117,800.00
-117,800.00
-103,900.00
-185,500.00
-102,700.00
EBIT
552,700.00
552,700.00
885,600.00
1,151,600.00
798,000.00
EBITDA
1,217,000.00
1,217,000.00
1,494,500.00
1,694,200.00
1,326,800.00
Reconciled Cost of Revenue
2,151,100.00
2,151,100.00
2,227,000.00
2,149,700.00
1,748,100.00
Reconciled Depreciation
565,000.00
565,000.00
504,400.00
450,700.00
426,000.00
Net Income from Continuing Operation Net Minority Interest
310,200.00
310,200.00
610,200.00
782,600.00
539,400.00
Total Unusual Items Excluding Goodwill
-17,200.00
-17,200.00
132,400.00
-17,300.00
-5,500.00
Total Unusual Items
-17,200.00
-17,200.00
132,400.00
-17,300.00
-5,500.00
Normalized EBITDA
1,234,200.00
1,234,200.00
1,362,100.00
1,711,500.00
1,332,300.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-4,695.60
-4,695.60
29,525.20
-4,480.70
-1,221.00
12/31/2020 - 10/27/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIM.PA bioMérieux S.A.
97.30
-1.07%
LONN.SW Lonza Group AG
511.00
-0.27%
MTO.F Mettler-Toledo International Inc.
1,112.50
-5.24%
CRL Charles River Laboratories International, Inc.
186.28
-0.78%
HTGMQ HTG Molecular Diagnostics, Inc.
0.0003
0.00%
MTD Mettler-Toledo International Inc.
1,187.32
+0.66%
MEDP Medpace Holdings, Inc.
307.57
-0.99%
IDXX IDEXX Laboratories, Inc.
422.94
+0.48%
WAT Waters Corporation
357.91
-0.15%
ICLR ICON Public Limited Company
187.29
-1.24%